"In our study, we showed that fine needle aspiration (FNA) biopsy material can be a good source for next-generation sequencing (NGS) for patients with metastatic prostate cancer. Based on these ...
Biomarker testing helps identify effective targeted therapies and avoid those that are less likely to work in certain ...
Recognized in the Healthcare category of the 2025 Top Innovations contest, Haystack MRD® enables minimal residual disease ...
This insightful review explores key areas of cancer genetic research, focusing on genes that may benefit from ...
Pansarcoma Analysis of Cyclin-Dependent Kinase and Cyclin Outlier Gene Expression Highlights CDK7 as a Potential Therapeutic Target in Chordoma Human epidermal growth factor 2 (HER2/ERBB2) has ...
The race for early cancer detection is one that physicians have been running for millennia. In one of humanity’s oldest surviving medical texts, the ancient Egyptian physician Imhotep described 46 ...
Processa Pharmaceuticals, Inc., a clinical-stage company specializing in next-generation cancer therapies, announced the acceptance of three abstracts for presentation at the 2025 American Society of ...